Zheng, Z.; Guo, Y.; Huang, X.; Liu, J.; Wang, R.; Qiu, X.; Liu, S.
CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer. Cancers 2022, 14, 4866.
https://doi.org/10.3390/cancers14194866
AMA Style
Zheng Z, Guo Y, Huang X, Liu J, Wang R, Qiu X, Liu S.
CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer. Cancers. 2022; 14(19):4866.
https://doi.org/10.3390/cancers14194866
Chicago/Turabian Style
Zheng, Zongtai, Yadong Guo, Xiongsheng Huang, Ji Liu, Ruiliang Wang, Xiaofu Qiu, and Shenghua Liu.
2022. "CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer" Cancers 14, no. 19: 4866.
https://doi.org/10.3390/cancers14194866
APA Style
Zheng, Z., Guo, Y., Huang, X., Liu, J., Wang, R., Qiu, X., & Liu, S.
(2022). CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer. Cancers, 14(19), 4866.
https://doi.org/10.3390/cancers14194866